Cardiovascular Disease Doctors in Bridgeport, CT Accepting Medicare

14 Cardiovascular Disease doctors found. Showing 1 - 14

Dr. Abdul Rahim Khan, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 285 Anton Dr, Bridgeport, CT 06606 Phone: 203-612-7201

Michael Logue, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 439 Mill Hill Ave, Bridgeport, CT 06610 Phone: 203-334-2100    Fax: 203-333-5864

Irma Fotjadhi, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 439 Mill Hill Ave, Bridgeport, CT 06610 Phone: 203-334-2100    Fax: 203-333-5864

Dr. Robert A Caserta, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2979 Main St, Bridgeport, CT 06606 Phone: 203-333-8800    Fax: 203-384-5157

Dr. Doron Amir, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 439 Mill Hill Ave, Bridgeport, CT 06610 Phone: 203-334-2100    Fax: 203-333-5864

Mr. Suhash R Patel, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 439 Mill Hill Ave, Bridgeport, CT 06610 Phone: 203-334-2100    Fax: 203-333-5864

Robert R. Tota, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 4675 Main St, Bridgeport, CT 06606 Phone: 203-683-5100    Fax: 203-683-5140

Edward Kosinski, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 4675 Main St, Bridgeport, CT 06606 Phone: 203-683-5100    Fax: 203-683-5140

Dr. Joseph A Rose, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2979 Main St, Bridgeport, CT 06606 Phone: 203-333-8800    Fax: 203-384-5157

Dr. Anja Wagner, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2979 Main St, Bridgeport, CT 06606 Phone: 203-683-5100    Fax: 203-683-5140

Venu Channamsetty, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2979 Main St, Bridgeport, CT 06606 Phone: 203-683-5110    Fax: 203-683-5140

Dr. Michael Victor Herman, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2800 Main St, Bridgeport, CT 06606 Phone: 203-576-5440    Fax: 203-576-5022

Dr. Kenneth R Lisi, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2979 Main St, Bridgeport, CT 06606 Phone: 203-333-8800    Fax: 203-384-5157

Craig A Mcpherson, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 226 Mill Hill Ave, 3rd Floor, Bridgeport, CT 06610 Phone: 203-384-3873    Fax: 203-384-3829

News Archive

FDA accepts Orexigen's Contrave NDA for treatment of obesity

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity.

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.

Effective strategy for noninvasive detection of cancer

Molecules that bind and illuminate proteins specific to tumor cells are key to detecting cancer as early as possible. The cyclooxygenase-2 enzyme is just such a protein, as the concentration of COX-2 is greater in cancer cells than in adjacent normal tissues.

Alimera submits Iluvien NDA for DME to FDA

Alimera Sciences, Inc.,, a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Iluvien®, (flucocinolone acetonide intravitreal insert), its investigational, sustained drug delivery system releasing sub-microgram levels of fluocinolone acetonide for the treatment of diabetic macular edema (DME).

Read more Medical News

› Verified 5 days ago